Morphology of 1-methyl-1-nitrosourea induced rat mammary tumours after treatment with precursor of phytanic acid or its combination with vitamin D analogue

Endocrine Regulations

Volumn 46, Issue 1, 2012, Pages 21-26

  Liska, J ^a,b   Macejova, D ^b   Ondkova, S ^b   Brtko, J ^b  

^a Institute of Histology and Embryology   (Slovakia)

^b INSTITUTE OF EXPERIMENTAL ENDOCRINOLOGY   (Slovakia)

Author keywords

1 methyl 1 nitrosourea; Mammary tumours; Phytol; Seocalcitol; Sprague dawley rats

Indexed keywords

METHYLNITROSOUREA; PHYTOL; PROPYLENE GLYCOL; SEOCALCITOL; ALKYLATING AGENT; ANTINEOPLASTIC AGENT; DRUG DERIVATIVE; PHYTANIC ACID; VITAMIN D;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; BREAST TUMOR; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; MICROSCOPY; NONHUMAN; RAT; TUMOR INVASION; TUMOR VOLUME; TUMOUR DETECTION; ANIMAL; CARCINOMA; CHEMICALLY INDUCED DISORDER; CHEMISTRY; COMPARATIVE STUDY; DISEASE COURSE; DRUG EFFECT; DRUG SCREENING; EXPERIMENTAL NEOPLASM; PATHOLOGY; SPRAGUE DAWLEY RAT;

ALKYLATING AGENTS; ANIMALS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA; DISEASE PROGRESSION; DRUG EVALUATION, PRECLINICAL; FEMALE; MAMMARY NEOPLASMS, EXPERIMENTAL; METHYLNITROSOUREA; PHYTANIC ACID; RATS; RATS, SPRAGUE-DAWLEY; TUMOR BURDEN; VITAMIN D;

EID: 84875883279     PISSN: 12100668     EISSN: 13360329     Source Type: Journal    
DOI: 10.4149/endo_2012_021     Document Type: Article

References (31)

1. Arnhold T, Elmazar MMA, Nau H: Prevention of Vitamin A Teratogenesis by Phytol or Phytanic Acid Results from Reduced Metabolism of Retinol to the Teratogenic Metabolite, All-trans-retinoic Acid. Toxicol Sci 66, 274-282, 2002. http://dx.doi.org/10.1093/toxsci/66.2.274
2. Avigan J: Te presence of phytanic acid in normal human and animal plasma. Biochim Biophys Acta 116, 391-394, 1966.
3. Brtko J: Retinoids, rexinoids and their cognate nuclear receptors: character and their role in chemoprevention of selected malignant diseases. Biomed Pap Med Fac Univ Palacky (Olomouc, Czech Repub) 151, 187-194, 2007.
4. Colston K W, Pirianov G, Bramm E, Hamberg KJ, Binderup L: Efects of Seocalcitol (EB1089) on nitrosomethyl urea-induced rat mammary tumors. Breast Cancer Res Treat 80, 303-311, 2003. http://dx.doi.org/10.1023/A:1024962316691
5. Costa I, Solanas M, Escrich E: Histopathologic characterization of mammary neoplastic lesions induced with 7,12 dimethylbenz(a)anthracene in the rat. a comparative analysis with human breast tumors. Arch Pathol Lab Med 126, 915-927, 2002.
6. Hussain MA, Tyagi SP, Tyagi N, Khan MH: Stromal response in breast tumors and allied lesions. J Indian Med Assoc 90, 119-121, 1992.
7. Kliewer SA, Umesono K, Noonan DJ, Heyman RA, Evans RM: Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors. Nature 358, 771 -774, 1992. http://dx.doi.org/10.1038/358771a0
8. Koshizuka K, Kubota T, Said J, Koike M, Binderup L, Uskokovic M, Koefer HP: Combination therapy of a vitamin D3 analog and all-trans-retinoic acid: efect on human breast cancer in nude mice. Anticancer Research 19, 519-24, 1999.
9. Lemotte PK, Keidel S, Apfel, ChM: Phytanic acid is a retinoid x receptor ligand. Eur J Biochem 236, 328-333, 1996. http://dx.doi.org/10.1111/j.1432-1033.1996.00328.x
10. Liska J, Galbavy S, Macejova D, Zlatos J, Brtko J: Histopathology of mammary tumours in female Sprague-Dawley rats treated with 1-methyl-1-nitrosourea. Endocrine Regul 34, 91-96, 2000.
11. Liska J, Zlatos J, Galbavy S, Macejova D, Stvrtina, S., Tuharska, M. Brtko, J: Morphology of rat mammary gland in the experiment. Plzen Lek Sborn Suppl 78, 91-94, 2003.
12. Macejova D, Ondkova S, Brtko J: Vitamin D3 affects expression of thyroid hormone receptor alpha and deiodinase activity in liver of MNU-treated Sprague-Dawley rats. Gen Physiol Biophys 28, 425-427, 2009. http://dx.doi.org/10.4149/gpb_2009_04_363
13. Macejova D, Ondkova S, Jakubikova L, Mlynarcikova A, Scsukova S, Liska J, Brtko J: MNU-induced mammary gland carcinogenesis: chemopreventive and therapeutic efects of vitamin D and Seocalcitol on selected regulatory vitamin D receptor pathways. Toxicol Lett 207, 60-72, 2011. http://dx.doi.org/10.1016/j.toxlet.2011.07.029
14. McCormick DL, Adamowski CB, Fiks A, Moon RC: Lifetime dose response relationships for mammmary tumor induction by a single administration of N-methyl-N-nitrosourea. Cancer Res 41, 1690-1694, 1981.
15. Mershon J, Sall W, Mitchner N, Ben-Jonathan N: Prolactin is a local growth factor in rat mammary tumors. Endocrinology 136, 3619-3623, 1995. http://dx.doi.org/10.1210/en.136.8.3619
16. Moon, RC: Comparative Aspects of Carotenoids and Retinoids as Chemopreventive Agents for Cancer. J Nutr 119, 127-134, 1989.
17. Ondkova S, Macejova D, Brtko J: Role of dihydroxyvitamin D(3) and its nuclear receptor in novel directed therapies for cancer. Gen Physiol Biophys 25, 339-53, 2006.
18. Rose D P, Pruitt B, Stauber P, Erturk E, Bryan GT: Infuence of Dosage Schedule on the Biological Characteristics of NNitrosomethylurea-induced Rat Mammary Tumors. Cancer Res 40, 235-239, 1980.
19. Russo J, Wilgus G, Russo IH: Susceptibility of the mammary gland to carcinogenesis. Diferentiation of the mammary gland as determinant of tumor incidence and the type of lesion. Am J Pathol 96, 721-736, 1979.
20. Russo J, Gusterson BA, Rogers AE, Russo IH, Wellings SR, van Zwieten MJ: Comparative study of human and rat mammary tumorigenesis. Lab Invest 62, 244-278, 1990a.
21. Russo J, Russo IH, Rogers AE, Van Zwieten MJ, Gusterson B: Pathology of tumours in laboratory animals. Tumours of the rat. Tumours of the mammary gland. IARC Sci Publ 99, 47-78, 1990b.
22. Russo J, Russo IH: Atlas and Histologic Classifcation of Tumors of the Rat Mammary Gland. J Mammary Gland Biol Neoplasia 5, 187-200, 2000. http://dx.doi.org/10.1023/A:1026443305758
23. Steinberg D, Avignan T, Mize C: Conversion of U-C'"phytol to phytanic acid and its oxidation in heredopathia atactica polyneuritiformis. Biochem Biophys Res Commun 19, 783-789, 1965. http://dx.doi.org/10.1016/0006291x(65)90328-1
24. Takahashi H, Uemura Y, Nakao I, Tsubura A: Induction of mammary carcinomas by the direct application of crystalline N-methyl-N-nitrosourea onto rat mammary gland. Cancer Lett 92, 105-111, 1995. http://dx.doi.org/10.1016/03043835(95)03761-K
25. Tompson HJ, Adlakha H: Dose-responsive Induction of Mammary Gland Carcinomas by the Intraperitoneal Injection of 1-methyl-1-nitrosourea. Cancer Res 51, 3411-3415, 1991.
26. Tompson HJ, Mcginley JN, Rothhammer K, Singh M: Rapid induction of mammary intraductal proliferation, ductal carcinoma in situ and carcinomas by the injection of sexually immature female rats with 1-methyl-1-nitrosourea. Carcinogenesis 16, 2407-2411, 1995. http://dx.doi.org/10.1093/carcin/16.10.2407
27. Van Zweiten MJ: Te rat as animal model in breast cancer research. In: V. Pathology of tumours in laboratory animals (Turusov V. Mohr U., Eds). Vol. 1, Tumours of the rat, pp 47-78, IARC Scientifc Publications, Lyon, 1990.
28. Verhoeven NM, Wanders RJ, Poll-Te BT, Saudubray JM, Jakobs C: Te metabolism ofphytanic acid and pristanic acid in man: a review. J Inherit Metab Dis 21, 697-728, 1998. http://dx.doi.org/10.1023/A:1005476631419
29. Vonderhaar BK: Prolactin involvement in breast cancer. Endocr Relat Cancer 6, 389-404, 1999. http://dx.doi.org/10.1677/erc.0.0060389
30. Wellings SR, Jensen HM, Marcum RG: An atlas of subgross pathology of the human breastwith special reference to possible precancerous lesions. J Natl Cancer Inst 55, 231-273, 1975.
31. Welsch CW: Host factors affecting the growth of carcinogen-induced rat mammary carcinomas: a review and tribute to Charles Brenton Huggins. Cancer Res. 45, 3415-3443, 1985.